Patents by Inventor Akihiro Haruno

Akihiro Haruno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080255253
    Abstract: The present invention provides an animal model for prostatic stromal hyperplasia, and a method for screening for a substance effective for preventing/treating human benign prostatic hyperplasia using the animal model. The animal model for prostatic stromal hyperplasia is produced by implanting the fetal urogenital sinus of a non-human animal under the skin or beneath the prostatic capsule of a non-human animal belonging to the species of the same as or different from the said animal. A substance effective for preventing/treating human benign prostatic hyperplasia can be screened by administering a test substance to the animal model and measuring the preventive or therapeutic effect of the test substance upon the implanted tissue (fetal urogenital sinus or tissue derived therefrom).
    Type: Application
    Filed: June 12, 2008
    Publication date: October 16, 2008
    Applicant: TAIHO PHARMACEUTICALS CO., LTD.
    Inventors: Nobuyuki Oda, Kazuhisa Miyoshi, Akihiro Haruno, Hidekazu Miyake
  • Patent number: 7417175
    Abstract: The present invention provides an animal model for prostatic stromal hyperplasia, and a method for screening for a substance effective for preventing/treating human benign prostatic hyperplasia using the animal model. The animal model for prostatic stromal hyperplasia is produced by implanting the fetal urogenital sinus of a non-human animal under the skin or beneath the prostatic capsule of a non-human animal belonging to the species of the same as or different from the animal. A substance effective for preventing/treating human benign prostatic hyperplasia can be screened by administering a test substance to the animal model and measuring the preventive or therapeutic effect of the test substance upon the implanted tissue (fetal urogenital sinus or tissue derived therefrom).
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: August 26, 2008
    Assignee: Taiho Pharmaceuticals Co., Ltd.
    Inventors: Nobuyuki Oda, Kazuhisa Miyoshi, Akihiro Haruno, Hidekazu Miyake
  • Publication number: 20040139486
    Abstract: The present invention provides an animal model for prostatic stromal hyperplasia, and a method for screening for a substance effective for preventing/treating human benign prostatic hyperplasia using the animal model. The animal model for prostatic stromal hyperplasia is produced by implanting the fetal urogenital sinus of a non-human animal under the skin or beneath the prostatic capsule of a non-human animal belonging to the species of the same as or different from the said animal. A substance effective for preventing/treating human benign prostatic hyperplasia can be screened by administering a test substance to the animal model and measuring the preventive or therapeutic effect of the test substance upon the implanted tissue (fetal urogenital sinus or tissue derived therefrom).
    Type: Application
    Filed: November 7, 2003
    Publication date: July 15, 2004
    Inventors: Nobuyuki Oda, Kazuhisa Miyoshi, Akihiro Haruno, Hidekazu Miyake